Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Posts 16-Percent Q4 Revenue Growth, Led by Life and Lab Sciences Segment

NEW YORK, Feb. 2 (GenomeWeb News) - Thermo Electron today reported a 16-percent increase in its fourth-quarter revenues, driven by a 21-percent increase in sales for its life and laboratory sciences segment.

 

The company reported total revenues of $613 million for the quarter ended Dec. 31, 2004, up from $529 million in the fourth quarter of 2003.

 

The company's life and laboratory sciences segment contributed $455 million in revenues for the quarter, up sharply from $377 million in the prior-year period. This performance was in contrast to Thermo's measurement and control business segment, which posted $158 million in fourth-quarter revenues - a 4-percent increase over year-ago revenues of $152 million.

 

In a statement, Thermo credited "strong sales" of its mass spectrometry and molecular spectroscopy instruments, laboratory automation systems, and laboratory informatics for driving life science revenues upward. This growth, however, was slightly offset by "extremely weak sales of our rapid point-of-care test kits resulting from this year's light flu season compared with an exceptionally strong quarter in 2003."

 

Thermo reported fourth-quarter R&D expenses of $34.9 million, up slightly from $32.2 million in the fourth quarter of 2003.

 

The company reported $121 million in GAAP net income for quarter, up from $61.9 million in the year-ago period. Adjusted net income was $62.2 million in the current quarter and $55.1 million in the comparable period of 2003.

 

Thermo held $430.8 million in cash and cash equivalents as of Dec. 31, 2004.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.